Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 67,108Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Finorga

02 1Aurobindo Pharma Limited

03 1MSN Laboratories Private Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioAsia
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAxplora- The partner of choice for complex APIs.

ENCORAFENIB

NDC Package Code : 62009-1913

Start Marketing Date : 2018-09-28

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Axplora CB

02

BioAsia
Not Confirmed
arrow

Looking for 1269440-17-6 / Encorafenib API manufacturers, exporters & distributors?

Encorafenib manufacturers, exporters & distributors 1

45

PharmaCompass offers a list of Encorafenib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Encorafenib manufacturer or Encorafenib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Encorafenib manufacturer or Encorafenib supplier.

PharmaCompass also assists you with knowing the Encorafenib API Price utilized in the formulation of products. Encorafenib API Price is not always fixed or binding as the Encorafenib Price is obtained through a variety of data sources. The Encorafenib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Encorafenib

Synonyms

Lgx818, 1269440-17-6, Lgx-818, Braftovi, Encorafenib (lgx818), Nvp-lgx818-nxa

Cas Number

1269440-17-6

Unique Ingredient Identifier (UNII)

8L7891MRB6

About Encorafenib

Encorafenib is an orally available Raf kinase inhibitor with potential antineoplastic activity. Encorafenib specifically inhibits Raf kinase, a serine/threonine enzyme in the RAF/mitogen-activated protein kinase kinase (MEK)/extracellular signal-related kinase (ERK) signaling pathway. By inhibiting the activation of the RAF/MEK/ERK signaling pathway, the administration of LGX818 may result in a decrease in proliferation of tumor cells. The Raf mutation BRAF V600E is frequently upregulated in a variety of human tumors and results in the constitutive activation of the RAF/MEK/ERK signaling pathway that regulates cellular proliferation and survival.

Encorafenib Manufacturers

A Encorafenib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Encorafenib, including repackagers and relabelers. The FDA regulates Encorafenib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Encorafenib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Encorafenib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Encorafenib Suppliers

A Encorafenib supplier is an individual or a company that provides Encorafenib active pharmaceutical ingredient (API) or Encorafenib finished formulations upon request. The Encorafenib suppliers may include Encorafenib API manufacturers, exporters, distributors and traders.

click here to find a list of Encorafenib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Encorafenib NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Encorafenib as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Encorafenib API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Encorafenib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Encorafenib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Encorafenib NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Encorafenib suppliers with NDC on PharmaCompass.

Encorafenib Manufacturers | Traders | Suppliers

Encorafenib Manufacturers, Traders, Suppliers 1
33

We have 3 companies offering Encorafenib

Get in contact with the supplier of your choice:

  1. Axplora
  2. Aurobindo Pharma Limited
  3. MSN Laboratories
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.